Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib/II Clinical Study of CVL006 Combination With 9MW2821 in Advanced Solid Tumors

NCT07615660 is registered in ClinicalTrials.gov with Convalife (Shanghai) Co., Ltd. as lead sponsor.

NCT NCT07615660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07615660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib/II Clinical Study of CVL006 Combination With 9MW2821 in Advanced Solid Tumors
Lead sponsor
Convalife (Shanghai) Co., Ltd.
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
May 15, 2026
Completion date
April 30, 2029
Enrollment
108 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor